|
||
Article |
Correspondence to Rudolf Leube: leube{at}uni-mainz.de
Plasticity of the resilient keratin intermediate filament cytoskeleton is an important prerequisite for epithelial tissue homeostasis. Here, the contribution of stress-activated p38 MAPK to keratin network organization was examined in cultured cells. It was observed that phosphorylated p38 colocalized with keratin granules that were rapidly formed in response to orthovanadate. The same p38p recruitment was noted during mitosis, in various stress situations and in cells producing mutant keratins. In all these situations keratin 8 became phosphorylated on S73, a well-known p38 target site. To demonstrate that p38-dependent keratin phosphorylation determines keratin organization, p38 activity was pharmacologically and genetically modulated: up-regulation induced keratin granule formation, whereas down-regulation prevented keratin filament network disassembly. Furthermore, transient p38 inhibition also inhibited keratin filament precursor formation and mutant keratin granule dissolution. Collectively, the rapid and reversible effects of p38 activity on keratin phosphorylation and organization in diverse physiological, stress, and pathological situations identify p38-dependent signalling as a major intermediate filamentregulating pathway.
| Introduction |
|---|
|
|
|---|
To examine direct linkages between kinase/phosphatase activities, keratin modifications, and KF organization, we therefore established epithelial cell culture systems in which we are able to monitor in real time the rapid and reversible orthovanadate (OV)-induced KF network disassembly into keratin granules by live-cell fluorescence microscopy (Strnad et al., 2002). Although overall keratin phosphorylation did not change substantially under these conditions (Strnad et al., 2002), keratin reorganization could be prevented by preincubation with a specific p38 MAPK inhibitor (Strnad et al., 2003). Because p38 is known to phosphorylate keratins (Feng et al., 1999; Ku et al., 2002; Toivola et al., 2002), we decided to analyze the relationship between its activity, modification of keratin target sites, and keratin arrangement in more detail.
| Results |
|---|
|
|
|---|
|
|
|
and ß isoforms of p38 (Davies et al., 2000). This treatment did not disrupt the KF network over a wide concentration range, although KFs appeared to coalesce and concentrate gradually in the central cytoplasm over time. When, in addition, cells were incubated with OV, keratin granule formation was efficiently prevented (compare Fig. 4 A with Fig. 4 B). To down-regulate p38 synthesis genetically, expression of p38 isoforms was first determined by RT-PCR.
,
, and
isoforms could be amplified from AK13-1 cells but not p38-ß. Therefore, plasmids were constructed encoding
-,
-, and
/
-specific p38 shRNAs together with fluorescent indicator proteins.
Transfected AK13-1 cells exhibited considerable reorganization of the keratin cytoskeleton in each instance (Fig. S3, A and B; available at http://www.jcb.org/cgi/content/full/jcb.200703174/DC1). A substantial depletion of KFs was seen in most parts of the cytoplasm, sparing only desmosome-anchored filaments. Most material coalesced in a juxtanuclear position. It still contained filaments that were compacted, but did not aggregate into granules. When these cells were treated with OV, the remaining filaments did not form granules as in neighboring nontransfected cells (Fig. 4, C and C').
|
Keratin granule formation coincides with a rapid increase in p38 and K8-S73 phosphorylation
To examine the extent of phosphorylation of p38 and keratins upon keratin granule formation, biochemical analyses were performed of cells treated with OV. A rapid and considerable rise of p38p was readily detectable in immunoblots of total cell lysates in response to OV (Fig. 5 A). Furthermore, reaction of cytoskeletal fractions with antibodies directed against K8-73p revealed a similarly rapid and coincident increase (Fig. 5 B), whereas no changes were observed for other keratin phosphoepitopes (Fig. 5 C).
To examine interactions between keratins and p38, coimmunoprecipitation experiments were performed. Using different detergents including NP-40 and empigen BB (Lowthert et al., 1995), we were able to detect p38p in anti-keratin precipitates from colon carcinoma-derived HT29 cells whose level was, however, not increased upon OV treatment in these cells or in AK13-1 cells (Fig. 5 D; unpublished data). Either we were not able to solubilize the newly formed keratin granules efficiently (see also Windoffer and Leube, 2001), and/or existing bonds were disrupted during cell fractionation.
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Our results in combination with many other publications (compare Inagaki et al., 1996; Izawa and Inagaki, 2006; Omary et al., 2006) strongly suggest that keratin phosphorylation is the primary mechanism by which the keratin network is reorganized. K8-S73 has received particular attention because it presents an on/off behavior during mitosis, in various stress situations including shear stress, and during apoptosis (Liao et al., 1997; Feng et al., 1999; Ridge et al., 2005). Furthermore, the sequence motif surrounding K8-S73 is conserved among several type II keratins as LLS/TPL where the corresponding threonine residue is also phosphorylated by p38 in an on/off fashion, leading to increased keratin solubilization, filament reorganization, and collapse during mitosis and UV- or anisomycin-induced apoptosis, as well as in psoriatic skin and squamous cell carcinoma (Toivola et al., 2002). Phosphorylation of sites in the head domain has been shown to be essential for the assembly of different IF types (Inagaki et al., 1990; Gibb et al., 1996; Gohara et al., 2001; Herrmann et al., 2003; Kreplak et al., 2004). The increase in negative charge by phosphorylation is believed to prevent interactions of the head domain with the negatively charged rod thereby keeping the head in an "open" configuration. Presumably, this configuration is part of opening up the filament structure during disassembly into granules and may also be needed during intermediate assembly steps. The observed p38-dependent and head domainspecific phosphorylation of K8-S73 before KF disassembly, as well as the inhibition of both KF precursor formation and mutant keratin granule disassembly by the p38 inhibitor SB202190, strongly support this notion (Videos 13). Yet, further experiments are needed to find out whether network disintegration into granules is due to keratin disassembly or simply a "clumping" of filaments, both of which may be determined by phosphorylation. Further support for the importance of head domain phosphorylation was provided for vimentin, in which case S55A mutants were shown to prevent network disassembly during mitosis (Chou et al., 1996). Similarly, light chain neurofilament S55D mutants interfered with proper neurofilament assembly in cultured cells and transgenic mice (Gibb et al., 1996, 1998). On the other hand, K8-S73p is not alone sufficient for KF network disruption (Fig. S3; Ku et al., 2002), indicating that additional p38 target sites in K8 and/or other keratins are necessary. Constitutive differences in overall keratin phosphorylation could well explain the different reactivities of KF networks in different cell types during mitosis and in various stress situations (compare Windoffer and Leube, 1999), and, even more, the observed lack of keratin reorganization in vivo, e.g., in K8-S73p-containing hepatocytes (Toivola et al., 2004). It has been proposed, therefore, that multiple events of phosphorylation and dephosphorylation cooperate in KF organization (Tao et al., 2006). Cooperation of several phosphorylation sites for IF formation has also been documented for GFAP in transgenic mice (Takemura et al., 2002), and the importance of cross talk between head and tail domain phosphorylation for neurofilament assembly in specific cellular topologies has been described (Zheng et al., 2003). Finally, we cannot exclude that p38 activity affects, in addition to keratins, factors which in turn regulate KF properties (Liao and Omary, 1996; Ku et al., 2004; Tao et al., 2005).
The strong and highly specific staining of cytoplasmic granules containing mutant keratins with antibodies against p38p and K8-S73p was not expected, and we were even more surprised to be able to almost instantaneously prevent keratin granule formation by pharmacological p38 inhibition. Interestingly, hyperphosphorylated keratin granules are present in toxic liver disease in the form of cytoplasmic Mallory bodies (Stumptner et al., 2000; Fickert et al., 2003; Toivola et al., 2004; Zatloukal et al., 2004), whose formation also relies on p38 activity (Nan et al., 2006). p38 activity is likely also relevant for other IF aggregates that occur in many different diseases, including cardiac myopathy, glial Alexander disease, and several neurodegenerative diseases (Al-Chalabi and Miller, 2003; Helfand et al., 2003; Omary et al., 2004). Notably, neurofilament aggregates that are formed in motoneurons of patients suffering from amyotrophic lateral sclerosis contain p38p together with phosphorylated NF-M and NF-H (Ackerley et al., 2004; Bendotti et al., 2004). A similar colocalization was also noted in a transgenic mouse model of amyotrophic lateral sclerosis (Tortarolo et al., 2003; Bendotti et al., 2004). In addition, mimicking-increased IF phosphorylation by expression of the NF-L S55D mutants led to prominent neuropathology with neurofilament inclusion bodies in neuronal perikarya and swollen axons in transgenic mice (Gibb et al., 1998).
While this investigation focused on the consequences of p38 recruitment for structural and dynamic properties of the keratin cytoskeleton, several publications have provided evidence that this interaction bears also important consequences for cell physiology. In particular, it has been suggested that keratins act as a phosphate "sponge" for stress-activated kinases based on observations in transgenic mice overexpressing K8-S73A and presenting increased susceptibility to liver injury and apoptosis (Ku and Omary, 2006). Our data, however, extend this model by demonstrating that activated p38 is not simply bound to the IF cytoskeleton, but also induces considerable organizational alterations and thereby affects cell shape, flexibility, and most likely other basic cellular functions (Kim et al., 2006).
| Materials and methods |
|---|
|
|
|---|
600- bp HindIII fragment encompassing the mutated part of K8 was excised and exchanged for the corresponding wild-type fragment in HK8-ECFPencoding plasmid that was described recently (Windoffer et al., 2004). In addition, a cDNA coding for K8-S73D mutant in a mammalian expression vector was also given to us by Dr. Omary (Ku et al., 2002). A p38-GFP cDNA was given to us by Dr. Bradham (Duke University, Durham, NC; Bradham and McClay, 2006). Flag-tagged cDNAs coding for constitutively active MKK3 (in pRc/RSV) and MKK6 (in pCDNA3) were provided by Dr. Davis (University of Massachusetts Medical School, Worcester, MA; Raingeaud et al., 1996). The HindIII/SpeI fragment coding for MKK3 was further subcloned into the corresponding sites of modified plasmid pTER (van de Wetering et al., 2003) containing additional CMV promoter-driven fragments coding for either ECFP (pTER-ECFP) or mRFP (pTER-mRFP; see Windoffer et al., 2006). In the case of MKK6, the MKK6-encoding plasmid and both pTER derivatives were cleaved with XbaI, blunt-ended, and cut with HindIII before ligation.
To specifically knock down p38 isoforms, shRNA-producing constructs were prepared. To this end, oligonucleotides encoding shRNAs were inserted into the BglII/HindIII sites of either pTER-ECFP or pTER-mRFP. For annealing, 10 pM of complementary oligonucleotides were incubated in annealing buffer (100 mM potassium acetate, 30 mM Hepes-KOH, pH 7.4, and 2 mM magnesium acetate) for 5 min at 95°C, 10 min at 70°C, and cooled down to room temperature. Subsequently, they were either stored at 20°C or used directly for ligation with plasmid DNA. Oligonucleotide pairs
1-sense/
1-antisense and
2-sense/
2-antisense were used to deplete p38
RNA, oligonucleotide pairs
2-sense/
2-antisense and
3-sense/
3-antisense to degrade p38
, and oligonucleotides
1/
1-sense/
1/
1-antisense to target p38
and
(Fig. S5).
RT-PCR
RT-PCR using the Enhanced Avian Reverse Transcriptase kit (Sigma- Aldrich) was performed for amplification of RNAs coding for specific p38 isoforms. The oligonucleotides used to amplify the
, ß,
, and
isoforms are listed in Fig. S5.
Cell culture
The following cell lines were propagated as described previously: vulva carcinoma-derived A431 cells of clones E3 and AK13-1 (Windoffer and Leube, 1999), colon adenocarcinoma-derived HT29 cells (ATCC HTB 38), spontaneously immortalized mammary epithelial EpH4 cells (compare Windoffer et al., 2006), and mammary adenocarcinoma-derived MCF7 cells of lines MT5K14-25 producing EYFP-K14 and MT5K14-26 synthesizing EYFP-K14R125C (Werner et al., 2004). Foreign DNA was transfected into subconfluent cells by using the Lipofectamine 2000 reagent following the instructions provided by the manufacturer (Invitrogen; Windoffer and Leube, 2004).
OV was obtained from Sigma-Aldrich and a 1M stock solution was prepared in ddH2O. The dissolved drug was added to subconfluent cultured cells in the dark at final concentrations between 10 and 30 mM for 510 min. To specifically inhibit p38
and ß activity, cells were treated with SB202190 (Sigma-Aldrich) at final concentrations ranging from 50 to 100 µM. To induce p38 activity pharmacologically, cells were incubated with anisomycin (Sigma-Aldrich) at 30 µM. In hyperosmotic stress assays, cells at 7080% confluence were incubated in medium containing 200 mM sorbitol for 525 min at 37°C before fixation. Hypoosmotic stress conditions were attained by incubation in medium supplemented with 150 mM urea for 515 min at 37°C. Cells recovered subsequently in normal medium for 520 min before further processing. For heat stress, subconfluent cells were placed in a 60°C incubator for 510 min and were then fixed.
Fluorescence microscopy and antibodies
In most instances cells were fixed by incubation for 5 min in 20°C cold methanole followed by a short 10-s treatment with 20° cold acetone. After air drying, cells were ready for antibody incubation. To detect soluble fluorescent proteins it was necessary to fix cells for 10 min at 4°C in 3% formaldehyde freshly prepared in PBS. A short 1-min treatment with 0.01% digitonin in PBS followed at room temperature. Alternatively, cells were treated with 20°C cold methanole for 10 min. After a subsequent 10-min incubation in 4°C PBS, cells were treated with 5% bovine serum albumin for 15 min at room temperature. Further antibody incubations followed in the same way as for methanol/acetone-fixed cells (Windoffer and Leube, 2004).
The following antibodies were used: polyclonal rabbit antibodies directed against total p38, dual phosphorylated p38 (recognizing T180p/Y182p), total JNK, JNKp, total ERK1/2, ERK1/2p, and against the Flag epitope DYDDDK were obtained from New England Biolabs, Inc.; murine monoclonal antibodies against dual phosphorylated p38 (recognizing T180p/Y182p) were from New England Biolabs Inc.; and monoclonal antibodies against K8-S73p (LJ4), K8-S431p (5B3), K18-S33p (IB4), and total K8/K18 (L2A1) were provided by Dr. Omary (Ku and Omary, 1997; Liao et al., 1997); secondary antibodies were ordered from Dianova and Rockland. Images were recorded with an inverse fluorescence microscope (IX-70; Olympus) and an attached slow scan camera (model IMAGO, Till Photonics; Windoffer and Leube, 2004; Windoffer et al., 2006). In some instances a confocal laser scanning microscope was used (SP5; Leica). Pictures were edited with Adobe Photoshop CS software to prepare figures.
Pearson coefficients were determined to quantify colocalization of different fluorescence patterns using Image-Pro Plus software (Media Cybernetics).
Live-cell imaging
Recording of phase-contrast images and fluorescence patterns on an inverse fluorescence microscope were performed as described previously (Windoffer and Leube, 2004; Windoffer et al., 2006).
Cell fractionation and immunoblotting
Total cell lysates were prepared by adding 200500 µl buffer (62.5 mM Tris-HCl, 2% [wt/vol] SDS, 10% glycerol, 50 mM DTT, and 0.01% [wt/vol] bromophenol blue) per 100 mm Petri dish. Solubilized cells were scraped off, sonicated briefly, and heated to 95°C for 5 min before SDS-PAGE. Cytoskeletal fractions were prepared by standard procedure (compare Windoffer and Leube, 2004). SDS-PAGE and immunoblotting was done as described previously (Strnad et al., 2002). In some instances, membranes were stripped by incubation in buffer containing 62.5 mM Tris, 2% (wt/vol) SDS, and 100 mM mercaptoethanol for 30 min at 55°C.
Immunoreactions were quantified by scanning fluorograms and analyzing reactive bands with Gel-Pro Analyzer software (Bio-Rad Laboratories). Integrated optic densities were determined from immunoblots run in parallel examining cell fractions from different experiments. The mean, SEM, and P values were calculated with SigmaStat (SYSTAT Software, Inc.).
For immunoprecipitation, cells were washed twice with PBS supplemented with 5 mM EDTA, scraped off, and solubilized in ice-cold buffer containing 1% NP-40, 5 mM EDTA, and 0.1 mM PMSF together with protease inhibitors (1 tablet of protease inhibitor cocktail "cOmplete" from Roche per 50 ml) by incubation at 4°C in a shaker for 2 h. Particles were centrifuged down at 18,000 g for 20 min at 4°C. Keratin antibody L2A1 was added to the supernatant. After incubation for 1 h, preequilibrated protein ASepharose CL-4B (GE Healthcare) was added and incubation at 4°C continued for another 2 h under constant agitation. Three brief wash steps in buffer containing 0.1% NP-40, 5 mM EDTA, and 0.1 mM PMSF followed and the remaining material was suspended in 62.5 mM Tris-HCl, 2% (wt/vol) SDS, 10% glycerol, and 0.01% (wt/vol) bromophenol blue, heated to 95°C for 2 min and subjected to SDS-PAGE.
Online supplemental material
The images shown in Fig. S1 (A and B) demonstrate that monoclonal antibodies directed against p38p present the same colocalization with keratin granules as other polyclonal antibodies (see Fig. 1). Similarly, fluorescent K18 and p38 chimeras colocalize in prominent cytoplasmic aggregates (Fig. S1, C and D). The fluorescence micrographs provided in Fig. S2 show that phosphorylation of K8-S431 is not affected by OV; those in Fig. S3 demonstrate that the keratin cytoskeleton is reorganized in response to p38 down-regulation and that K8-S73D mutation does not affect overall network formation. Fig. S4 summarizes colocalization results for keratins and specific keratin phosphoepitopes or phosphorylated p38, JNKs, and ERKs during various situations of pronounced KF network alterations. Fig. S5 lists the oligonucleotides used for cloning. Videos 1 and 2 corresponding to Fig. 10, A and B, respectively, reveal the inhibitory effects of pharmacological p38 inactivation on KF precursor formation. Video 3 further shows that p38 inhibition prevents mutant keratin granule turnover. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200703174/DC1.
| Acknowledgments |
|---|
The work was supported by the German Research Council.
Submitted: 27 March 2007
Accepted: 4 May 2007
| References |
|---|
|
|
|---|
Ackerley, S., A.J. Grierson, S. Banner, M.S. Perkinton, J. Brownlees, H.L. Byers, M. Ward, P. Thornhill, K. Hussain, J.S. Waby, et al. 2004. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 26:354364.[CrossRef][Medline]
Al-Chalabi, A., and C.C. Miller. 2003. Neurofilaments and neurological disease. Bioessays. 25:346355.[CrossRef][Medline]
Bakin, A.V., C. Rinehart, A.K. Tomlinson, and C.L. Arteaga. 2002. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115:31933206.
Bendotti, C., C. Atzori, R. Piva, M. Tortarolo, M.J. Strong, S. DeBiasi, and A. Migheli. 2004. Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J. Neuropathol. Exp. Neurol. 63:113119.[Medline]
Berkowitz, P., P. Hu, Z. Liu, L.A. Diaz, J.J. Enghild, M.P. Chua, and D.S. Rubenstein. 2005. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J. Biol. Chem. 280:2377823784.
Bradham, C.A., and D.R. McClay. 2006. p38 MAPK is essential for secondary axis specification and patterning in sea urchin embryos. Development. 133:2132.
Cano, E., Y.N. Doza, R. Ben-Levy, P. Cohen, and L.C. Mahadevan. 1996. Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene. 12:805812.[Medline]
Chen, W., and G.T. Bowden. 1999. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene. 18:74697476.[CrossRef][Medline]
Cheng, H., J. Kartenbeck, K. Kabsch, X. Mao, M. Marques, and A. Alonso. 2002. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol. J. Cell. Physiol. 192:234243.[CrossRef][Medline]
Cheng, T.J., and Y.K. Lai. 1998. Identification of mitogen-activated protein kinase-activated protein kinase-2 as a vimentin kinase activated by okadaic acid in 9L rat brain tumor cells. J. Cell. Biochem. 71:169181.[CrossRef][Medline]
Chou, Y.H., P. Opal, R.A. Quinlan, and R.D. Goldman. 1996. The relative roles of specific N- and C-terminal phosphorylation sites in the disassembly of intermediate filament in mitotic BHK-21 cells. J. Cell Sci. 109:817826.[Abstract]
Coulombe, P.A., and M.B. Omary. 2002. Hard and soft principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14:110122.[CrossRef][Medline]
Coulombe, P.A., and P. Wong. 2004. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6:699706.[CrossRef][Medline]
D'Alessandro, M., D. Russell, S.M. Morley, A.M. Davies, and E.B. Lane. 2002. Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock. J. Cell Sci. 115:43414351.
Davies, S.P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95105.[CrossRef][Medline]
Eckert, R.L., T. Efimova, S.R. Dashti, S. Balasubramanian, A. Deucher, J.F. Crish, M. Sturniolo, and F. Bone. 2002. Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase. J. Investig. Dermatol. Symp. Proc. 7:3640.[CrossRef][Medline]
Eckert, R.L., T. Efimova, S. Balasubramanian, J.F. Crish, F. Bone, and S. Dashti. 2003. p38 Mitogen-activated protein kinases on the body surfacea function for p38 delta. J. Invest. Dermatol. 120:823828.[CrossRef][Medline]
Efimova, T., A.M. Broome, and R.L. Eckert. 2003. A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J. Biol. Chem. 278:3427734285.
Feng, L., X. Zhou, J. Liao, and M.B. Omary. 1999. Pervanadate-mediated tyrosine phosphorylation of keratins 8 and 19 via a p38 mitogen-activated protein kinase-dependent pathway. J. Cell Sci. 112:20812090.[Abstract]
Fickert, P., M. Trauner, A. Fuchsbichler, C. Stumptner, K. Zatloukal, and H. Denk. 2003. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. J. Hepatol. 38:387394.[CrossRef][Medline]
Fontao, L., B. Favre, S. Riou, D. Geerts, F. Jaunin, J.H. Saurat, K.J. Green, A. Sonnenberg, and L. Borradori. 2003. Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus. Mol. Biol. Cell. 14:19781992.
Garmyn, M., T. Mammone, A. Pupe, D. Gan, L. Declercq, and D. Maes. 2001. Human keratinocytes respond to osmotic stress by p38 map kinase regulated induction of HSP70 and HSP27. J. Invest. Dermatol. 117:12901295.[CrossRef][Medline]
Gibb, B.J., J. Robertson, and C.C. Miller. 1996. Assembly properties of neurofilament light chain Ser55 mutants in transfected mammalian cells. J. Neurochem. 66:13061311.[Medline]
Gibb, B.J., J.P. Brion, J. Brownlees, B.H. Anderton, and C.C. Miller. 1998. Neuropathological abnormalities in transgenic mice harbouring a phosphorylation mutant neurofilament transgene. J. Neurochem. 70:492500.[Medline]
Gibbons, I.R., A. Lee-Eiford, G. Mocz, C.A. Phillipson, W.-J.Y. Tang, and B.H. Gibbons. 1987. Photosensitized cleavage of dynein heavy chains. J. Biol. Chem. 262:27802786.
Gohara, R., D. Tang, H. Inada, M. Inagaki, Y. Takasaki, and S. Ando. 2001. Phosphorylation of vimentin head domain inhibits interaction with the carboxyl-terminal end of alpha-helical rod domain studied by surface plasmon resonance measurements. FEBS Lett. 489:182186.[CrossRef][Medline]
Harper, E.G., S.M. Alvares, and W.G. Carter. 2005. Wounding activates p38 map kinase and activation transcription factor 3 in leading keratinocytes. J. Cell Sci. 118:34713485.
Hatzfeld, M., and C. Nachtsheim. 1996. Cloning and characterization of a new armadillo family member, p0071, associated with the junctional plaque: evidence for a subfamily of closely related proteins. J. Cell Sci. 109:27672778.[Abstract]
He, T., A. Stepulak, T.H. Holmstrom, M.B. Omary, and J.E. Eriksson. 2002. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J. Biol. Chem. 277:1076710774.
Helfand, B.T., L. Chang, and R.D. Goldman. 2003. The dynamic and motile properties of intermediate filaments. Annu. Rev. Cell Dev. Biol. 19:445467.[CrossRef][Medline]
Herrmann, H., M. Hesse, M. Reichenzeller, U. Aebi, and T.M. Magin. 2003. Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int. Rev. Cytol. 223:83175.[Medline]
Hofmann, I., C. Mertens, M. Brettel, V. Nimmrich, M. Schnolzer, and H. Herrmann. 2000. Interaction of plakophilins with desmoplakin and intermediate filament proteins: an in vitro analysis. J. Cell Sci. 113:24712483.[Abstract]
Hofmann, M., J. Zaper, A. Bernd, J. Bereiter-Hahn, R. Kaufmann, and S. Kippenberger. 2004. Mechanical pressure-induced phosphorylation of p38 mitogen-activated protein kinase in epithelial cells via Src and protein kinase C. Biochem. Biophys. Res. Commun. 316:673679.[CrossRef][Medline]
Inagaki, M., Y. Gonda, K. Nishizawa, S. Kitamura, C. Sato, S. Ando, K. Tanabe, K. Kikuchi, S. Tsuiki, and Y. Nishi. 1990. Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J. Biol. Chem. 265:47224729.
Inagaki, M., Y. Matsuoka, K. Tsujimura, S. Ando, T. Tokui, T. Takahashi, and N. Inagaki. 1996. Dynamic property of intermediate filaments: regulation by phosphorylation. Bioessays. 18:481487.[CrossRef]
Izawa, I., and M. Inagaki. 2006. Regulatory mechanisms and functions of intermediate filaments: a study using site- and phosphorylation state-specific antibodies. Cancer Sci. 97:167174.[CrossRef][Medline]
Johansen, C., K. Kragballe, M. Westergaard, J. Henningsen, K. Kristiansen, and L. Iversen. 2005. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br. J. Dermatol. 152:3742.[CrossRef][Medline]
Kim, S., P. Wong, and P.A. Coulombe. 2006. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature. 441:362365.[CrossRef][Medline]
Klekotka, P.A., S.A. Santoro, and M.M. Zutter. 2001. alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J. Biol. Chem. 276:95039511.
Kowalczyk, A.P., M. Hatzfeld, E.A. Bornslaeger, D.S. Kopp, J.E. Borgwardt, C.M. Corcoran, A. Settler, and K.J. Green. 1999. The head domain of plakophilin-1 binds to desmoplakin and enhances its recruitment to desmosomes. Implications for cutaneous disease. J. Biol. Chem. 274:1814518148.
Kreplak, L., U. Aebi, and H. Herrmann. 2004. Molecular mechanisms underlying the assembly of intermediate filaments. Exp. Cell Res. 301:7783.[CrossRef][Medline]
Ku, N.O., and M.B. Omary. 1997. Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J. Biol. Chem. 272:75567564.
Ku, N.O., and M.B. Omary. 2006. A disease- and phosphorylation-related nonmechanical function for keratin 8. J. Cell Biol. 174:115125.
Ku, N.O., S. Azhar, and M.B. Omary. 2002. Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J. Biol. Chem. 277:1077510782.
Ku, N.O., H. Fu, and M.B. Omary. 2004. Raf-1 activation disrupts its binding to keratins during cell stress. J. Cell Biol. 166:479485.
Leung, C.L., K.J. Green, and R.K. Liem. 2002. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol. 12:3745.[CrossRef][Medline]
Liao, J., and M.B. Omary. 1996. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J. Cell Biol. 133:345357.
Liao, J., N.O. Ku, and M.B. Omary. 1997. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 272:1756517573.
Listwan, P., and J.A. Rothnagel. 2004. Keratin bundling proteins. Methods Cell Biol. 78:817827.[Medline]
Lowthert, L.A., N.O. Ku, J. Liao, P.A. Coulombe, and M.B. Omary. 1995. Empigen BB: a useful detergent for solubilization and biochemical analysis of keratins. Biochem. Biophys. Res. Commun. 206:370379.[CrossRef][Medline]
Magin, T.M., P. Vijayaraj, and R.E. Leube. 2007. Structural and regulatory functions of keratins. Exp. Cell Res. In press.
Nan, L., J. Dedes, B.A. French, F. Bardag-Gorce, J. Li, Y. Wu, and S.W. French. 2006. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. Exp. Mol. Pathol. 80:228240.[CrossRef][Medline]
Omary, M.B., P.A. Coulombe, and W.H. McLean. 2004. Intermediate filament proteins and their associated diseases. N. Engl. J. Med. 351:20872100.
Omary, M.B., N.O. Ku, G.Z. Tao, D.M. Toivola, and J. Liao. 2006. Heads and tails of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 31:383394.[CrossRef][Medline]
Raingeaud, J., A.J. Whitmarsh, T. Barrett, B. Derijard, and R.J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:12471255.[Abstract]
Rezniczek, G.A., L. Janda, and G. Wiche. 2004. Plectin. Methods Cell Biol. 78:721755.[Medline]
Ridge, K.M., L. Linz, F.W. Flitney, E.R. Kuczmarski, Y.H. Chou, M.B. Omary, J.I. Sznajder, and R.D. Goldman. 2005. Keratin 8 phosphorylation by protein kinase C delta regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J. Biol. Chem. 280:3040030405.
Schweizer, J., P.E. Bowden, P.A. Coulombe, L. Langbein, E.B. Lane, T.M. Magin, L. Maltais, M.B. Omary, D.A. Parry, M.A. Rogers, and M.W. Wright. 2006. New consensus nomenclature for mammalian keratins. J. Cell Biol. 174:169174.
Sharma, G.D., J. He, and H.E. Bazan. 2003. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J. Biol. Chem. 278:2198921997.